We concluded that in the DLBCL models tested, IRF8 mutations did not stimulate cell growth and were more akin to KO models, which led us to consider the possibility that these variants may represent a cancer cell intrinsic defect that primarily influences the lymphoma microenvironment. Here, IRF8 is linked to cancer.